The Patent Finder

Professional Dietetics S.p.A.

12 patents currently held · Updated Nov 16, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Dec 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 29, 2027
    The maintenance fee for Combination for the treatment of radiation- or chemotherapy-induced mucositis (US 9,220,726) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy (US 11,896,569) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases (US 11,957,651) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,220,726Combination for the treatment of radiation- or chemotherapy-induced mucositis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,272,059Aminoacid-Based Composition for Fibroelastin Recovery in Dermal Connective Tissues
In force
 · High confidence
In forceHigh confidence
US 11,234,949Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,896,569Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,337,946Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,452,702Compositions Comprising Amino Acids for Use in the Treatment of Mitochondrial Dysfunction-Related Diseases
In force
 · Medium confidence
In forceMedium confidence
US 11,957,651Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,239,622Compositions comprising amino acids for use in the prevention and treatment of liver diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,527,759Compositions Comprising Amino Acids for Use and Treatment of Central Nervous System Injuries
In force
 · High confidence
In forceHigh confidence
US 12,472,159Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
Also on record, not counted in the 12: 3 patents in force now held by others · 8 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited